Alector, Inc.
Alector develops immunology-based therapies for neurodegenerative diseases including Alzheimer's and Parkinson's disease.
10-QNov 12Latest SEC filing
Nov 3Latest story
November 2026
October 2026
September 2026
August 2026
July 2026
Alector develops immunology-based therapies for neurodegenerative diseases including Alzheimer's and Parkinson's disease.
November 2026
October 2026
September 2026
August 2026
July 2026